Evidence map›Paper›PMID 16381608›Full record

ArticleBMC bioinformatics2005

Comparison of normalization methods for CodeLink Bioarray data.

Wei Wu, Nilesh Dave, George C Tseng, Thomas Richards, Eric P Xing, Naftali Kaminski

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in BMC bioinformatics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2017
    Article
  6. Article
  7. Article
  8. Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  9. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine · 2014
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Quality Visualization of Microarray Datasets Using Circos.Microarrays (Basel, Switzerland) · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei WuDorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. wuw2@upmc.edu
Nilesh Dave
George C Tseng
Thomas Richards
Eric P Xing
Naftali Kaminski

Funding

New Molecular Targets in Pulmonary FibrosisR01HL073745 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMINSKI, NAFTALI · 2003 to 2006
$2.8M
Proteomics of Idiopathic Pulmonary FibrosisR21HL079394 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMINSKI, NAFTALI · 2005 to 2006
$404k
Lung vascular responses--intermittent/sustained hypoxiaF32HL078164 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVE, NILESH B · 2004 to 2005
$108k
NHLBI NIH HHS F32 HL078164NHLBI NIH HHS F32 HL78164-2NHLBI NIH HHS HL 073745-01NHLBI NIH HHS HL079394-01NHLBI NIH HHS R01 HL073745NHLBI NIH HHS R21 HL079394
6 · The paper itself

Abstract

backgroundThe quality of microarray data can seriously affect the accuracy of downstream analyses. In order to reduce variability and enhance signal reproducibility in these data, many normalization methods have been proposed and evaluated, most of which are for data obtained from cDNA microarrays and Affymetrix GeneChips. CodeLink Bioarrays are a newly emerged, single-color oligonucleotide microarray platform. To date, there are no reported studies that evaluate normalization methods for CodeLink Bioarrays.

resultsWe compared five existing normalization approaches, in terms of both noise reduction and signal retention: Median (suggested by the manufacturer), CyclicLoess, Quantile, Iset, and Qspline. These methods were applied to two real datasets (a time course dataset and a lung disease-related dataset) generated by CodeLink Bioarrays and were assessed using multiple statistical significance tests. Compared to Median, CyclicLoess and Qspline exhibit a significant and the most consistent improvement in reduction of variability and retention of signal. CyclicLoess appears to retain more signal than Qspline. Quantile reduces more variability than Median in both datasets, yet fails to consistently retain more signal in the time course dataset. Iset does not improve over Median in either noise reduction or signal enhancement in the time course dataset.

conclusionMedian is insufficient either to reduce variability or to retain signal effectively for CodeLink Bioarray data. CyclicLoess is a more suitable approach for normalizing these data. CyclicLoess also seems to be the most effective method among the five different normalization strategies examined.

Indexed as

AlgorithmsDatabases, GeneticModels, GeneticComputer SimulationData Interpretation, StatisticalGene Expression ProfilingModels, StatisticalOligonucleotide Array Sequence AnalysisReference StandardsSoftwareSoftware Validation

Identifiers

PMID16381608
PMCPMC1373657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.